A geospatial assessment of industrial releases and pediatric neuroblastic tumours at diagnosis: A retrospective case series
Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital i...
Saved in:
Published in | Archives of environmental & occupational health Vol. 78; no. 9-10; pp. 455 - 470 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
2023
Kirkpatrick Jordon Foundation |
Subjects | |
Online Access | Get full text |
ISSN | 1933-8244 2154-4700 2154-4700 |
DOI | 10.1080/19338244.2023.2291734 |
Cover
Abstract | Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations. |
---|---|
AbstractList | Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (
= 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (
= 0.02,
= 0.04, and
= 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05,
= 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations. Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01–1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations. Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations.Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations. |
Author | Franklin, Meredith Tambasco, Domenica Tibout, Pauline Doria, Andrea S. Harris, Shelley A. |
Author_xml | – sequence: 1 givenname: Domenica surname: Tambasco fullname: Tambasco, Domenica organization: Department of Family and Community Medicine, Women's College Hospital, Environmental Health Clinic and University of Toronto – sequence: 2 givenname: Meredith surname: Franklin fullname: Franklin, Meredith organization: Department of Statistical Sciences and School of the Environment, University of Toronto – sequence: 3 givenname: Shelley A. surname: Harris fullname: Harris, Shelley A. organization: Divisions of Epidemiology & Occupational and Environmental Health, Dalla Lana School of Public Health – sequence: 4 givenname: Pauline surname: Tibout fullname: Tibout, Pauline organization: Division of Hematology and Oncology, The Hospital for Sick Children – sequence: 5 givenname: Andrea S. surname: Doria fullname: Doria, Andrea S. organization: Department of Diagnostic Imaging, Research Institute, The Hospital for Sick Children and Department of Medical Imaging, University of Toronto |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38190263$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9v1DAQxS1URLcLHwFkiQuXLPbY-ceJVQUUqRIXOFuzzqRyldiL7YAqvjyOdsuBQ0-W_X4z4zfvil344Imx11LspOjEe9kr1YHWOxCgdgC9bJV-xjYga13pVogLtlmZaoUu2VVK90LoFnp4wS5VJ3sBjdqwP3t-RyEdMTucOKZEKc3kMw8jd35YUo6rEGkiLBpHP_AjDQ7Lu-WelhgOE6ZcLnmZwxILknnR73xILn3g-1KbY5lANrtfxG1pwxNFR-klez7ilOjV-dyyH58_fb--qW6_ffl6vb-trNKQKwTsirtmqKkehWqxB00koR1Hawm1laNShI1WiMWiJDgoICVl06OsYVBb9u7U9xjDz4VSNrNLlqYJPYUlmbI7qKGWbV3Qt_-h98WTL78rFCgQXVN2umVvztRymGkwx-hmjA_mca0FqE-ALc5TpPEfIoVZ4zOP8Zk1PnOOr9R9PNU5P4Y44-8Qp8FkfJhCHCN665JRT7f4CzOaocs |
Cites_doi | 10.1371/journal.pbio.2002800 10.1186/1476-072X-3-28 10.1186/s13046-022-02281-w 10.1080/10408444.2020.1801575 10.1007/s11004-008-9211-3 10.1016/B978-0-12-802916-9.00010-5 10.1016/j.reprotox.2017.06.044 10.1503/cmaj.071783 10.1080/08880018.2021.1979147 10.1097/00001648-200101000-00005 10.1136/jech.2004.031674 10.1097/MPH.0000000000000416 10.3390/ijerph6123190 10.3389/fnmol.2019.00009 10.3390/ijerph15081625 10.1016/B978-0-12-819092-0.00014-5 10.1016/j.envint.2016.04.023 10.1542/peds.2012-2757 10.1136/archdischild-2017-314032 10.1097/MPH.0b013e3181bcc809 10.1097/EDE.0000000000001156 10.1080/00039899909602220 10.1016/j.envres.2017.03.009 10.1157/13076768 10.1016/j.tox.2007.10.012 10.1177/019262330002800125 10.1007/s10552-018-1011-6 10.1002/cncr.20910 10.1016/j.cppeds.2016.08.004 10.1186/1476-069X-10-S1-S8 10.1111/j.1365-3016.2008.00983.x 10.1016/j.envres.2013.09.002 10.1097/MOP.0b013e32832925cc 10.1023/a:1008951632482 10.1093/carcin/bgr297 10.1038/bjc.2014.358 10.3390/ijerph15030505 10.1016/j.pedhc.2021.05.005 10.1016/j.freeradbiomed.2010.07.028 10.1186/s13104-021-05506-x 10.26444/aaem/94299 10.1007/s00381-011-1483-0 10.1136/jech.2004.021675 10.1080/00039896.1993.9938369 10.1093/aje/154.2.106 10.22541/au.165486268.87677869/v1 10.6091/ibj.1230.2013 10.1093/aje/kwv120 10.1016/0378-4274(81)90024-2 |
ContentType | Journal Article |
Copyright | 2024 Taylor & Francis Group, LLC 2024 2024 Taylor & Francis Group, LLC |
Copyright_xml | – notice: 2024 Taylor & Francis Group, LLC 2024 – notice: 2024 Taylor & Francis Group, LLC |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1080/19338244.2023.2291734 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Occupational Therapy & Rehabilitation |
EISSN | 2154-4700 |
EndPage | 470 |
ExternalDocumentID | 38190263 10_1080_19338244_2023_2291734 2291734 |
Genre | Research Article Journal Article |
GroupedDBID | -~X .7F .QJ 0BK 0R~ 23N 30N 354 36B 4.4 4P2 53G 5GY 6J9 7X7 8F7 AAENE AAIKC AAJMT AALDU AAMIU AAMNW AAPUL AAQRR ABCCY ABDBF ABFIM ABJNI ABLIJ ABPAQ ABPEM ABTAI ABXUL ABXYU ACGFS ACGOD ACTIO ACUHS ADCVX ADGTB AEGXH AEISY AENEX AEOZL AEPSL AEYOC AFRAH AGDLA AGMYJ AHDZW AHMBA AIJEM AKBVH AKOOK ALIPV ALMA_UNASSIGNED_HOLDINGS ALQZU AQRUH AVBZW AWYRJ B0M BENPR BLEHA CCCUG CS3 DGEBU DKSSO EAP EAS EBB EBC EBD EBS EDH EHB EHE EHN EMB EMK EMOBN EPL EPT ESX E~A E~B F5P GTTXZ GUQSH H13 HCIFZ HF~ HZ~ H~9 H~P IPNFZ J.P KYCEM L7B LJTGL M0R M2O M2P M4Z NA5 NX0 O9- OHH OVD QN7 Q~Q RIG RNANH ROSJB RTWRZ S-T SNACF SV3 TBQAZ TDBHL TEI TEORI TFL TFT TFW TQWBC TTHFI TUROJ TUS UT5 UU3 VVN WH7 ZGOLN ZY1 ~8M ~S~ AAGDL AAHIA AAYXX ADYSH AFRVT AIYEW AMPGV CITATION EBX 7XC 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 AAGME ABFMO ABRLO ABUWG ACBNA ACDHJ ACZPZ ADBBV ADOPC AEUYN AFKRA ATCPS AURDB AZQEC BCR BCU BEC BES BFWEY BHPHI BKNYI BLC BPHCQ BVXVI CCPQU CGR CUY CVF CWRZV DWQXO ECM EIF EJD FYUFA GNUQQ HMCUK K9- M1P M2Q NPM NUSFT OHT P-O PATMY PCLFJ PEA PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PYCSY QF4 QM4 QO4 S0X SJFOW TASJS UKHRP ZE2 ZXP K9. 7X8 |
ID | FETCH-LOGICAL-c342t-a2a89176d5e5f037a924ee127ffccea4c1f33ea643aa0041e2b32e31169a152d3 |
ISSN | 1933-8244 2154-4700 |
IngestDate | Fri Sep 05 09:35:03 EDT 2025 Mon Jul 14 10:42:46 EDT 2025 Mon Jul 21 06:00:29 EDT 2025 Tue Jul 01 02:56:10 EDT 2025 Wed Dec 25 09:06:54 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9-10 |
Keywords | neuroblastoma industrial ganglioneuroblastoma geospatial Emissions pediatric |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c342t-a2a89176d5e5f037a924ee127ffccea4c1f33ea643aa0041e2b32e31169a152d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 38190263 |
PQID | 2923208693 |
PQPubID | 28654 |
PageCount | 16 |
ParticipantIDs | informaworld_taylorfrancis_310_1080_19338244_2023_2291734 pubmed_primary_38190263 crossref_primary_10_1080_19338244_2023_2291734 proquest_miscellaneous_2912525175 proquest_journals_2923208693 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-00-00 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – year: 2023 text: 2023-00-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Archives of environmental & occupational health |
PublicationTitleAlternate | Arch Environ Occup Health |
PublicationYear | 2023 |
Publisher | Taylor & Francis Kirkpatrick Jordon Foundation |
Publisher_xml | – name: Taylor & Francis – name: Kirkpatrick Jordon Foundation |
References | e_1_3_4_3_1 e_1_3_4_61_1 e_1_3_4_63_1 e_1_3_4_9_1 e_1_3_4_42_1 e_1_3_4_7_1 e_1_3_4_40_1 e_1_3_4_5_1 e_1_3_4_23_1 e_1_3_4_46_1 e_1_3_4_69_1 e_1_3_4_21_1 e_1_3_4_44_1 e_1_3_4_27_1 e_1_3_4_65_1 e_1_3_4_25_1 e_1_3_4_48_1 e_1_3_4_67_1 e_1_3_4_29_1 National Research Council (US). (e_1_3_4_72_1) 2007 e_1_3_4_74_1 e_1_3_4_53_1 e_1_3_4_30_1 e_1_3_4_51_1 e_1_3_4_70_1 e_1_3_4_13_1 e_1_3_4_34_1 e_1_3_4_59_1 e_1_3_4_11_1 e_1_3_4_32_1 e_1_3_4_17_1 e_1_3_4_38_1 e_1_3_4_15_1 e_1_3_4_36_1 e_1_3_4_57_1 e_1_3_4_19_1 e_1_3_4_4_1 e_1_3_4_2_1 e_1_3_4_62_1 e_1_3_4_64_1 e_1_3_4_8_1 e_1_3_4_20_1 e_1_3_4_41_1 e_1_3_4_6_1 e_1_3_4_60_1 e_1_3_4_24_1 e_1_3_4_45_1 e_1_3_4_22_1 e_1_3_4_43_1 e_1_3_4_28_1 e_1_3_4_49_1 e_1_3_4_66_1 e_1_3_4_26_1 e_1_3_4_47_1 e_1_3_4_68_1 Centre for Surveillance and Applied Research, Public Health Agency of Canada (e_1_3_4_55_1) 2023 e_1_3_4_73_1 e_1_3_4_75_1 e_1_3_4_31_1 e_1_3_4_52_1 e_1_3_4_50_1 e_1_3_4_71_1 e_1_3_4_12_1 e_1_3_4_35_1 e_1_3_4_58_1 e_1_3_4_10_1 e_1_3_4_33_1 e_1_3_4_54_1 e_1_3_4_16_1 e_1_3_4_39_1 e_1_3_4_14_1 e_1_3_4_37_1 e_1_3_4_56_1 e_1_3_4_18_1 |
References_xml | – ident: e_1_3_4_70_1 doi: 10.1371/journal.pbio.2002800 – ident: e_1_3_4_36_1 – ident: e_1_3_4_39_1 doi: 10.1186/1476-072X-3-28 – ident: e_1_3_4_61_1 doi: 10.1186/s13046-022-02281-w – ident: e_1_3_4_60_1 doi: 10.1080/10408444.2020.1801575 – ident: e_1_3_4_52_1 – ident: e_1_3_4_13_1 doi: 10.1007/s11004-008-9211-3 – ident: e_1_3_4_15_1 doi: 10.1016/B978-0-12-802916-9.00010-5 – ident: e_1_3_4_66_1 – ident: e_1_3_4_12_1 doi: 10.1016/j.reprotox.2017.06.044 – ident: e_1_3_4_14_1 doi: 10.1503/cmaj.071783 – ident: e_1_3_4_22_1 doi: 10.1080/08880018.2021.1979147 – ident: e_1_3_4_74_1 – ident: e_1_3_4_26_1 doi: 10.1097/00001648-200101000-00005 – ident: e_1_3_4_49_1 – ident: e_1_3_4_27_1 doi: 10.1136/jech.2004.031674 – ident: e_1_3_4_35_1 doi: 10.1097/MPH.0000000000000416 – ident: e_1_3_4_68_1 doi: 10.3390/ijerph6123190 – ident: e_1_3_4_51_1 – ident: e_1_3_4_62_1 doi: 10.3389/fnmol.2019.00009 – ident: e_1_3_4_6_1 – ident: e_1_3_4_3_1 – ident: e_1_3_4_11_1 doi: 10.3390/ijerph15081625 – ident: e_1_3_4_37_1 – ident: e_1_3_4_59_1 doi: 10.1016/B978-0-12-819092-0.00014-5 – ident: e_1_3_4_63_1 doi: 10.1016/j.envint.2016.04.023 – ident: e_1_3_4_34_1 doi: 10.1542/peds.2012-2757 – ident: e_1_3_4_19_1 doi: 10.1136/archdischild-2017-314032 – ident: e_1_3_4_31_1 doi: 10.1097/MPH.0b013e3181bcc809 – ident: e_1_3_4_56_1 – ident: e_1_3_4_16_1 doi: 10.1097/EDE.0000000000001156 – ident: e_1_3_4_48_1 – ident: e_1_3_4_53_1 – volume-title: Cancer in Young People in Canada Data Tool. 2020 Edition. Public Health Infobase year: 2023 ident: e_1_3_4_55_1 – ident: e_1_3_4_9_1 doi: 10.1080/00039899909602220 – ident: e_1_3_4_64_1 doi: 10.1016/j.envres.2017.03.009 – ident: e_1_3_4_20_1 doi: 10.1157/13076768 – ident: e_1_3_4_43_1 doi: 10.1016/j.tox.2007.10.012 – ident: e_1_3_4_10_1 doi: 10.1177/019262330002800125 – ident: e_1_3_4_30_1 doi: 10.1007/s10552-018-1011-6 – volume-title: Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology. Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment year: 2007 ident: e_1_3_4_72_1 – ident: e_1_3_4_75_1 – ident: e_1_3_4_2_1 doi: 10.1002/cncr.20910 – ident: e_1_3_4_69_1 doi: 10.1016/j.cppeds.2016.08.004 – ident: e_1_3_4_71_1 doi: 10.1186/1476-069X-10-S1-S8 – ident: e_1_3_4_18_1 doi: 10.1111/j.1365-3016.2008.00983.x – ident: e_1_3_4_47_1 – ident: e_1_3_4_42_1 doi: 10.1016/j.envres.2013.09.002 – ident: e_1_3_4_17_1 doi: 10.1097/MOP.0b013e32832925cc – ident: e_1_3_4_41_1 doi: 10.1023/a:1008951632482 – ident: e_1_3_4_58_1 doi: 10.1093/carcin/bgr297 – ident: e_1_3_4_50_1 – ident: e_1_3_4_25_1 doi: 10.1038/bjc.2014.358 – ident: e_1_3_4_38_1 – ident: e_1_3_4_32_1 doi: 10.3390/ijerph15030505 – ident: e_1_3_4_23_1 doi: 10.1016/j.pedhc.2021.05.005 – ident: e_1_3_4_73_1 – ident: e_1_3_4_5_1 – ident: e_1_3_4_40_1 doi: 10.1016/j.freeradbiomed.2010.07.028 – ident: e_1_3_4_54_1 – ident: e_1_3_4_46_1 – ident: e_1_3_4_67_1 doi: 10.1186/s13104-021-05506-x – ident: e_1_3_4_21_1 doi: 10.26444/aaem/94299 – ident: e_1_3_4_29_1 doi: 10.1007/s00381-011-1483-0 – ident: e_1_3_4_28_1 doi: 10.1136/jech.2004.021675 – ident: e_1_3_4_8_1 doi: 10.1080/00039896.1993.9938369 – ident: e_1_3_4_65_1 – ident: e_1_3_4_33_1 doi: 10.1093/aje/154.2.106 – ident: e_1_3_4_24_1 doi: 10.22541/au.165486268.87677869/v1 – ident: e_1_3_4_7_1 – ident: e_1_3_4_4_1 – ident: e_1_3_4_44_1 doi: 10.6091/ibj.1230.2013 – ident: e_1_3_4_57_1 doi: 10.1093/aje/kwv120 – ident: e_1_3_4_45_1 doi: 10.1016/0378-4274(81)90024-2 |
SSID | ssj0047292 |
Score | 2.3235724 |
Snippet | Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 455 |
SubjectTerms | Aluminum Benzene Carcinogenicity Carcinogens Child Comparative analysis Diagnosis Dioxins Emissions Environmental Pollutants Environmental risk Exposure Furans ganglioneuroblastoma geospatial Humans Hydrocarbons industrial Industrial emissions Malignancy Neoplasms neuroblastoma Nitrogen dioxide pediatric Pediatrics Pesticides Regression analysis Regression models Residential location Retrospective Studies Risk factors Statistical analysis Tumors |
Title | A geospatial assessment of industrial releases and pediatric neuroblastic tumours at diagnosis: A retrospective case series |
URI | https://www.tandfonline.com/doi/abs/10.1080/19338244.2023.2291734 https://www.ncbi.nlm.nih.gov/pubmed/38190263 https://www.proquest.com/docview/2923208693 https://www.proquest.com/docview/2912525175 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZKV1rtBcHyKizISMClSknsNA9uFQ9VSMsBumLFJXKTCeqhTdWmh11-En-SmdhOXNEVj0tUxbWddj7ZM8433zD2oggAQ64g9yBXVMKsKLw0HSdeWMQQSQpCVMPy_RRNL8KPl-PLXu-nw1ra1fNRfn0wr-R_rIr30K6UJfsPlm0HxRv4Ge2LV7QwXv_KxpPhd6i2xImmjP9WY1PLQLQlOagsCu5VWox5bUtzDBslyzk6zyTZWu-WOOGWUhsLTb5bbHXS-gbqTWXzMYc5DjSk32aohwf0a53UOZyckFW5SsY68bI7MFjiPppX2pfHPg51yK0nf04lRRddv6nabLQ6wpeGyXrVncnOFsS1tqxHSxswBxs663gEzdKHfkjohbHvu-t0nDh4TD3DhtXrbqi1fn_bDzSBEp1UmaAfM6JpRkJgiKpPUB2MrJcNSCiAxbBUdttjS1q0TbfYkYijSPTZ0WT67ttXu_GHGKcImySW-K8PznrCju04e57Qnk7uzdFO4_XM7rDbJlzhE429u6wHq1N2fG4IGafspatSzWdaooK_4p_3BODvsR8T3kGVd1DlVck7qHILVY5Q5S1UuQtVbqDKVc1bqL7hE74HVE5A5Rqo99nFh_ezt1PP1P3wchmK2lNCJfhnRcUYxqUvY5WKECAQcVnmOagwD0opQaEvrRTpxYGYSwEyCKJUoTtayAesv6pW8IhxH5LCj6O0wIFDBTCPFaDPS3tVKZMiHbCRtUG21vIuWWBUc639MrJfZuw3YKlrqaxuztVKXQQnk3_oe2bNmplVZJshZqTwkyiVA_a8bcY1nl7cqRVUO_oOhiGkLTgesIcaDu3TWjQ9vrHlCTuhp9DnhmesX2928BQ96Xr-zCD4F3aqy3w |
linkProvider | Library Specific Holdings |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BkaAXHuXRhQJGAm4JGztPbitEtUC7B7SVerMce4IqxKZqshf488zE8WoXqeLQc2xr7IxnvrHH3wC8dQlSyJXYCK3hEmbORVWVlVHqCswVByFmyPJd5POz9Ot5dr71FobTKjmGbjxRxGCreXPzYXRIiftAoEOV5Jdirv0dS0khh0pvw52M4Din9anpIljjlMCj9DfLKuI-4RXPdcPs-Kcd9tLrMejgi44fgA2z8CkoP-N1X8f29z8Ejzeb5kO4P0JVMfO69Qhu4eoA7p6Ol_EH8G6boVgsPT2BeC--75B_P4Y_M_ED245bUjuzoQIVbSMuNpVDBFdvIZfaCRJYXIYKImIg3KwJ45MUol__IqmoSS-czxG86D6KGfXtr9rwaFRYGkbw1sLuCZwdf15-mkdjzYfIqlT2kZGmpHnmLsOsmarCUHyImMiiaaxFk9qkUQoN4ShjmCsMZa0kqiTJK0NQxKmnsLdqV3gIYoqlmxZ55Wjg1CDWhUHCO2ynGlW6agJx-NP60lN76GRkTA1Lr3np9bj0E6i29UH3w5lK4wugaPWfvkdBefRoJTpNqqkkxZSVmsCbzWfa33xpY1bYrrkNQVDmlcsm8Mwr3UZajrYphlbPbyDYa7g3X56e6JMvi28vYJ8_-ROmI9jrr9b4kjBXX78aNtVfUc0f0w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BkSouPMproYCRgFvSxJMntxWwKq8VQq3EzXLiMaoQm1WTvcCfZxzHqy5SxaFnPzR2xjPfxONvAF6alDjkStuIWu1KmBkT1XVeRZkpqUAXhOgxy3dZHJ9mH7_nIZuwn9IqXQxtPVHEaKvd4V4bGzLijhhzYMVuKXalv2MpOeLA7DrcKBKsHX0-JstgjDPGjtJfLGPkxoRHPJdNs-OedshLL4egoyta3IYmLMJnoPyMN0MTt7__4Xe80irvwK0JqIq516y7cI1WB7D_ZbqKP4BXF_mJxYknJxCvxbcd6u978GcuflDXu57cT2-JQEVnxdm2bohwtVvYofaC5RXrUD9EjHSbDSN8lkIMm18sFXcZhPEZgmf9GzHnscN5F56MipanEe5gUX8fThfvT94eR1PFh6jFTA6RlrridRYmp9wmWGqODolSWVrbtqSzNrWIpBlFae2Ywkg2KAnTtKg1AxGDD2Bv1a3oEYiEKpOURW144kwTNaUmRjvOSlmsTD2DOHxotfbEHiqd-FLD1iu39Wra-hnUF9VBDeMfFevLnyj8z9jDoDtqshG9Ys1EyRFljTN4sW3m0-2ubPSKuo3rwwDUscrlM3jodW4rrYu1OYLGx1cQ7Dnsf323UJ8_LD89gZuuxf9eOoS94XxDTxlwDc2z8Uj9BclUHoA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+geospatial+assessment+of+industrial+releases+and+pediatric+neuroblastic+tumours+at+diagnosis%3A+A+retrospective+case+series&rft.jtitle=Archives+of+environmental+%26+occupational+health&rft.au=Tambasco%2C+Domenica&rft.au=Franklin%2C+Meredith&rft.au=Harris%2C+Shelley+A&rft.au=Tibout%2C+Pauline&rft.date=2023&rft.eissn=2154-4700&rft.volume=78&rft.issue=9-10&rft.spage=455&rft_id=info:doi/10.1080%2F19338244.2023.2291734&rft_id=info%3Apmid%2F38190263&rft.externalDocID=38190263 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1933-8244&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1933-8244&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1933-8244&client=summon |